European Sleep-Wake Disorder Market Size to Reach $10.7 Billion by 2035

European sleep-wake disorder market is projected to grow from $6.0 billion in 2025 and is projected to reach $10.7 billion by 2035, growing at a CAGR of 6.0% during the forecast period 2026-2035. The European sleep-wake disorder market is experiencing steady development due to increasing awareness regarding the long-term health effects associated with untreated sleep conditions. Healthcare providers across the region are placing greater emphasis on early diagnosis and integrated treatment approaches for disorders such as insomnia, sleep apnea, and circadian rhythm disturbances. The expansion of specialized sleep clinics and the growing availability of home-based diagnostic tools are supporting broader patient access to care. In addition, changing work patterns, rising stress levels, and lifestyle-related health concerns are contributing to higher demand for sleep management solutions. Public health initiatives promoting mental wellness and preventive healthcare are also influencing the adoption of sleep-related therapies and monitoring systems.

Browse the full report description of “European Sleep-Wake Disorder Market Size, Share & Trends Analysis By Disorder Type (Insomnia, Hypersomnia, Sleep Apnea, Circadian Rhythm Sleep-Wake Disorders, Parasomnias, Dyssomnias, and Others), By Treatment Type (Pharmacological Therapy, Behavioral Therapy, Light Therapy, Device-Based Therapy, and Others), By Diagnosis & Management Approach (Polysomnography & Sleep Studies, Actigraphy-Based Monitoring, Clinical Evaluation & Screening Tools, and Remote/Digital Sleep Monitoring Solutions), and By Application (Hospitals, Home Care Settings, and Others), Forecast Period (2026-2035)” at https://www.omrglobal.com/industry-reports/european-sleep-wake-disorder-market

A notable trend within the European market is the increasing integration of digital technologies in sleep disorder diagnosis and treatment management. Healthcare systems are gradually incorporating remote monitoring platforms, wearable devices, and connected therapeutic equipment to improve patient follow-up and long-term treatment adherence. The market is also witnessing growing interest in non-pharmacological therapies, including behavioral interventions and personalized care programs. Collaboration between healthcare institutions, technology developers, and medical device manufacturers is supporting innovation in patient-centered sleep care. Furthermore, regulatory support for digital health solutions and continued investment in healthcare infrastructure are contributing to the ongoing evolution of sleep disorder management practices across Europe.

Competitive Landscape of the Sleep-Wake Disorder Market

The key players in the sleep-wake disorder market are Koninklijke Philips N.V., Jazz Pharmaceuticals plc, Sanofi, H. Lundbeck A/S, and LivaNova PLC, among others. Market participants are focusing on expanding therapeutic portfolios and strengthening digital sleep care capabilities to address the growing burden of sleep-related disorders across Europe. Companies are increasingly investing in advanced diagnostic technologies, connected respiratory devices, and neuroscience-based treatment approaches to improve patient management. Strategic collaborations with healthcare providers and research institutions are also supporting the development of personalized and long-term treatment solutions. In addition, ongoing innovation in remote monitoring and home-based care systems continues to influence the competitive landscape of the market.

• In December 2025, ResMed Inc received regulatory clearance for its AI-enabled Smart Comfort technology designed to personalize CPAP therapy settings for patients with obstructive sleep apnea. The solution utilizes machine learning and real-world sleep data to improve therapy adherence and patient comfort. According to the company, the technology is expected to support broader deployment of intelligent sleep therapy systems beginning in early 2026. The launch highlights the growing role of artificial intelligence in sleep disorder management and personalized respiratory care. The company has also continued expanding its digital sleep ecosystem across Europe through connected devices and patient engagement platforms.

Market Coverage

• The market number available for – 2025-2035
• Base year- 2025
• Forecast period- 2026-2035
• Segment Covered-
  • By Disorder Type
  • By Treatment Type
  • By Diagnosis & Management Approach
  • By Application
• Competitive Landscape - Koninklijke Philips N.V., Jazz Pharmaceuticals plc, Sanofi, H. Lundbeck A/S, and LivaNova PLC.

Key questions addressed by the report.

• What is the market growth rate?
• Which segment and region dominate the market in the base year?
• Which segment and region will project the fastest growth in the market?
• Who is the leader in the market?
• How are players addressing challenges to sustain growth?
• Where is the investment opportunity?

European Sleep-Wake Disorder Market Report Segment

By Disorder Type

• Insomnia
• Hypersomnia
• Sleep Apnea
• Circadian Rhythm Sleep-Wake Disorders
• Parasomnias
• Dyssomnias
• Others

By Treatment Type

• Pharmacological Therapy
• Behavioral Therapy
• Light Therapy
• Device-Based Therapy
• Others

By Diagnosis & Management Approach

• Polysomnography & Sleep Studies
• Actigraphy-Based Monitoring
• Clinical Evaluation & Screening Tools
• Remote / Digital Sleep Monitoring Solutions

By Application

• Hospitals
• Home Care Settings
• Others

European Sleep-Wake Disorder Market Report Segment by Country

• UK
• Germany
• Italy
• Spain
• France
• Russia
• Rest of Europe

To learn more about this report request a sample copy @ https://www.omrglobal.com/request-sample/european-sleep-wake-disorder-market